CMPX Compass Therapeutics, Inc.
Fundamentals / CIK 0001738021 / USDCompass Therapeutics, Inc. reported $0 in revenue and a net loss of $86.36M for the fiscal year ended December 31, 2025 (down 100.0% year over year).
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CMPX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025$0 -100.0% YoY
-
Operating Income FY 2025-$94.07M Operating profit
-
Net Income FY 2025-$86.36M GAAP bottom line
-
Diluted EPS FY 2025-- Split-adjusted
-
Free Cash Flow FY 2025-$61.94M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$163.1M Total debt: $9.23M
Annual revenue and net income
9 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Mar 31 | Dec 31 | Mar 31 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $850K | $0 | -- | -- | -- | -- | -- | -- |
| Research & Development | $55.97M | $42.34M | $38.12M | $30.00M | $20.34M | $14.90M | -- | $22.45M | -- |
| Total Operating Expenses | $72.84M | $57.48M | $50.36M | $41.66M | $81.88M | $27.81M | -- | $34.05M | -- |
| Operating Income | -$72.84M | -$56.62M | -$50.36M | -$41.66M | -$81.88M | -$27.81M | -$32K | -$34.05M | -$33K |
| EBITDA | -$72.56M | -$56.04M | -$49.66M | -$40.87M | -$81.28M | -$25.41M | -- | -$31.95M | -- |
| Interest Income | $6.40M | $7.30M | $7.90M | $2.36M | $29K | $88K | -- | $743K | -- |
| Interest Expense | -- | -- | -- | $0 | $370K | $908K | $5.4K | $1.23M | $3.3K |
| Income Before Tax | -- | -- | -$42.49M | -$39.23M | -$82.18M | -$29.47M | -- | -$34.65M | -- |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $32K | -- | $91K | -- |
| Net Income | -$66.49M | -$49.38M | -$42.49M | -$39.23M | -$82.18M | -$29.50M | -$37K | -$34.74M | -$36K |
| Basic EPS | -$0.42 | -$0.36 | -$0.33 | -$0.37 | -$1.31 | -$0.96 | -$0.01 | -$5.19 | -$0.01 |
| Diluted EPS | -- | -- | -- | -- | -$1.31 | -$0.96 | -$0.01 | -$5.19 | -$0.01 |
| Basic Shares Outstanding | 157.7M | 137.4M | 127.0M | 105.2M | 62.9M | 30.8M | 5.0M | 6.7M | 5.0M |
| Diluted Shares Outstanding | -- | 137.4M | -- | -- | 62.9M | 30.8M | 5.0M | 6.7M | 5.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $0 | $0 | -- | -- |
| Research & Development | $22.04M | $19.58M | $13.39M | $13.67M | $12.83M | $16.41M | $13.05M | $13.04M |
| Total Operating Expenses | $28.80M | $26.98M | $20.30M | $17.99M | $15.82M | $21.07M | $17.97M | $16.57M |
| Operating Income | -$28.80M | -$26.98M | -$20.30M | -$17.99M | -$15.82M | -$21.07M | -$17.97M | -$16.57M |
| EBITDA | -$28.77M | -$26.96M | -$20.28M | -$17.97M | -$15.80M | -$20.97M | -$17.83M | -$16.43M |
| Interest Income | -- | -- | -- | -- | -- | $1.20M | $1.30M | $1.60M |
| Income Before Tax | -- | -- | -- | -- | -- | -- | -$16.63M | -- |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | $0 | -- |
| Net Income | -$27.17M | -$25.15M | -$18.32M | -$15.72M | -$14.26M | -$19.88M | -$16.63M | -$15.03M |
| Basic EPS | -$0.15 | -$0.13 | -$0.10 | -- | -$0.08 | -$0.14 | -$0.12 | -- |
| Basic Shares Outstanding | 186.8M | 186.8M | 186.4M | -- | 168.8M | 138.3M | 138.2M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | -- | -- | 138.2M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Mar 31 | Dec 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $30.64M | $43.48M | $24.23M | $34.95M | $144.5M | $47.08M | $3.7K | $25.30M | $4.9K | -- |
| Short-Term Investments | $178.3M | $83.24M | $128.2M | $151.7M | $0 | -- | -- | -- | -- | -- |
| Cash & Short-Term Investments | $208.9M | $126.7M | $152.5M | $186.6M | $144.5M | $47.08M | $3.7K | $25.30M | $4.9K | -- |
| Total Current Assets | $209.8M | $132.8M | $153.9M | $194.8M | $147.1M | $50.20M | $3.7K | $26.24M | $4.9K | $25 |
| Property, Plant & Equipment, Net | $102K | $353K | $898K | $1.57M | $2.24M | $1.13M | -- | $3.75M | -- | -- |
| Other Non-Current Assets | -- | $568K | $320K | $320K | $320K | $320K | -- | $129K | -- | -- |
| Total Non-Current Assets | $9.77M | $7.65M | $2.99M | $4.85M | $6.65M | $1.71M | $0 | $4.14M | $0 | $0 |
| Total Assets | $219.6M | $140.4M | $156.9M | $199.6M | $153.8M | $51.91M | $3.7K | $30.38M | $4.9K | $25 |
| Accounts Payable | $1.58M | $2.25M | $4.09M | $3.38M | $867K | $1.06M | -- | $629K | -- | -- |
| Short-Term Debt | -- | -- | -- | -- | $0 | $7.47M | -- | $5.58M | -- | -- |
| Total Current Liabilities | $13.97M | $8.87M | $7.80M | $16.17M | $10.63M | $10.10M | $112K | $9.82M | $75K | $35K |
| Long-Term Debt | -- | -- | -- | -- | $0 | $1.87M | -- | $9.29M | -- | -- |
| Total Non-Current Liabilities | $8.83M | $6.30M | $536K | $1.84M | $3.05M | $1.87M | $0 | $9.29M | $0 | $0 |
| Total Liabilities | $22.80M | $15.17M | $8.34M | $18.01M | $13.68M | $11.97M | $112K | $19.11M | $75K | $35K |
| Total Debt (incl. Leases) | $9.83M | $6.63M | $1.73M | $2.94M | $4.04M | $9.33M | -- | $14.87M | -- | -- |
| Common Stock | $18K | $14K | $13K | $13K | $10K | $5.0K | $500 | $1.0K | $500 | $500 |
| Retained Earnings | -$431.2M | -$364.7M | -$315.3M | -$272.8M | -$233.6M | -$151.4M | -$109K | -$121.9M | -$71K | -$35K |
| Accumulated Other Comp. Income | $280K | $210K | $37K | -$302K | $0 | -- | -- | -- | -- | -- |
| Total Stockholders' Equity | $196.8M | $125.2M | $148.5M | $181.6M | $140.1M | $39.95M | -$124.8M | $11.27M | -$95.29M | -$35K |
| Total Equity | $196.8M | $125.2M | $148.5M | $181.6M | $140.1M | $39.95M | -$124.8M | $11.27M | -$95.29M | -$35K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $41.47M | $35.45M | $55.17M | $30.64M | $46.21M | $22.86M | $41.05M | $43.48M |
| Short-Term Investments | $121.6M | $144.4M | $139.5M | $178.3M | $173.7M | $78.09M | $71.59M | $83.24M |
| Cash & Short-Term Investments | $163.1M | $179.9M | $194.7M | $208.9M | $219.9M | $100.9M | $112.6M | $126.7M |
| Total Current Assets | $165.5M | $180.9M | $195.7M | $209.8M | $221.1M | $106.2M | $124.1M | $132.8M |
| Property, Plant & Equipment, Net | $402K | $324K | $169K | $102K | $119K | $131K | $102K | $353K |
| Other Non-Current Assets | -- | -- | -- | -- | -- | -- | -- | $568K |
| Total Non-Current Assets | $9.00M | $9.28M | $9.48M | $9.77M | $10.14M | $10.50M | $7.31M | $7.65M |
| Total Assets | $174.5M | $190.2M | $205.2M | $219.6M | $231.3M | $116.7M | $131.5M | $140.4M |
| Accounts Payable | $6.32M | $2.91M | $906K | $1.58M | $3.10M | $2.60M | $1.58M | $2.25M |
| Total Current Liabilities | $24.37M | $16.13M | $10.28M | $13.97M | $12.41M | $13.86M | $14.90M | $8.87M |
| Total Non-Current Liabilities | $7.56M | $8.00M | $8.42M | $8.83M | $9.23M | $9.63M | $6.27M | $6.30M |
| Total Liabilities | $31.93M | $24.12M | $18.70M | $22.80M | $21.65M | $23.49M | $21.17M | $15.17M |
| Total Debt (incl. Leases) | $9.23M | $9.63M | $9.79M | $9.83M | $9.83M | $9.90M | $6.38M | $6.63M |
| Common Stock | $18K | $18K | $18K | $18K | $53K | $14K | $14K | $14K |
| Retained Earnings | -$501.8M | -$474.6M | -$449.5M | -$431.2M | -$415.5M | -$401.2M | -$381.3M | -$364.7M |
| Accumulated Other Comp. Income | -$566K | -$251K | -$159K | $280K | $274K | $208K | $190K | $210K |
| Total Stockholders' Equity | $142.6M | $166.0M | $186.5M | $196.8M | $209.6M | $93.21M | $110.3M | $125.2M |
| Total Equity | $142.6M | $166.0M | $186.5M | $196.8M | $209.6M | $93.21M | $110.3M | $125.2M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Mar 31 | Dec 31 | Mar 31 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$66.49M | -$49.38M | -$42.49M | -$39.23M | -$82.18M | -$29.50M | -$37K | -$34.74M | -$36K |
| Depreciation & Amortization | $276K | $589K | $699K | $782K | $600K | $2.40M | -- | $2.10M | -- |
| Stock-Based Compensation | $8.37M | $8.56M | $6.12M | $5.33M | $4.03M | $4.02M | -- | $915K | -- |
| Change in Payables | -$664K | -$1.84M | $708K | $2.52M | -$194K | $432K | -- | -$1.10M | -- |
| Operating Cash Flow | -$49.14M | -$44.85M | -$40.62M | -$34.12M | -$19.67M | -$26.80M | -$32K | -$31.74M | -$33K |
| Capital Expenditure | -$25K | -$44K | -$30K | -$212K | -$1.57M | -$106K | -- | -$466K | -- |
| Free Cash Flow | -$49.17M | -$44.90M | -$40.65M | -$34.34M | -$21.23M | -$26.91M | -- | -$32.21M | -- |
| Acquisitions, Net | -- | -- | -- | $0 | -$318K | -- | -- | -- | -- |
| Purchases of Investments | -$194.6M | -$88.16M | -$155.4M | -$200.1M | $0 | -- | -- | -- | -- |
| Investing Cash Flow | -$93.31M | $46.77M | $26.96M | -$151.2M | -$1.77M | $38K | -- | -$466K | -- |
| Common Stock Issued | $138.0M | $18.11M | $3.13M | $76.24M | $128.3M | $60.48M | -- | -- | -- |
| Financing Cash Flow | $129.6M | $17.34M | $2.94M | $75.76M | $118.6M | $48.54M | $31K | -- | $38K |
| Net Change in Cash | -$12.84M | $19.25M | -$10.72M | -$109.6M | $97.17M | $21.77M | -$1.1K | -$32.21M | $4.9K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$27.17M | -$25.15M | -$18.32M | -$15.72M | -$14.26M | -$19.88M | -$16.63M | -$15.03M |
| Depreciation & Amortization | $28K | $21K | $15K | $17K | $19K | $100K | $140K | $140K |
| Stock-Based Compensation | $4.01M | $4.82M | $5.07M | $1.82M | $1.24M | $2.79M | $2.51M | $2.24M |
| Change in Payables | $3.41M | $2.00M | -$679K | -$1.51M | $500K | $1.02M | -$672K | $1.29M |
| Operating Cash Flow | -$16.32M | -$14.74M | -$17.27M | -$13.25M | -$10.85M | -$11.83M | -$13.21M | -$9.16M |
| Capital Expenditure | -$106K | -$176K | -$82K | $0 | -$7.0K | $0 | -$18K | $0 |
| Free Cash Flow | -$16.42M | -$14.91M | -$17.35M | -$13.25M | -$10.86M | -$11.83M | -$13.23M | -$9.16M |
| Purchases of Investments | -$5.54M | -$40.62M | -$44.81M | -$27.48M | -$109.1M | -$33.17M | -$24.83M | -$9.86M |
| Investing Cash Flow | $22.33M | -$4.98M | $38.43M | -$3.38M | -$95.16M | -$6.36M | $11.59M | $15.37M |
| Common Stock Issued | -- | -- | -- | $0 | $138.0M | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $3.37M | $1.06M | $129.4M | $0 | -$815K | -$94K |
| Net Change in Cash | $6.02M | -$19.71M | $24.52M | -$15.57M | $23.36M | -$18.19M | -$2.44M | $6.11M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Mar 31 | Dec 31 | Mar 31 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -6661.8% | -- | -- | -- | -- | -- | -- | -- |
| Net Profit Margin | -- | -5808.8% | -- | -- | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -33.8% | -39.4% | -28.6% | -21.6% | -58.7% | -73.9% | -- | -308.4% | -- |
| Return on Assets (ROA) | -30.3% | -35.2% | -27.1% | -19.6% | -53.4% | -56.8% | -1000.9% | -114.4% | -740.6% |
| Current Ratio | 15.02x | 14.96x | 19.73x | 12.05x | 13.84x | 4.97x | 0.03x | 2.67x | 0.06x |
| Quick Ratio | 14.96x | 14.28x | 19.54x | 11.54x | 13.59x | 4.66x | 0.03x | 2.58x | 0.06x |
| Debt to Equity | 0.05x | 0.05x | 0.01x | 0.02x | 0.03x | 0.23x | -- | 1.32x | -- |
| Revenue Growth (YoY) | -100.0% | -- | -- | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -60.6% | -44.2% | -36.6% | -33.8% | -31.4% | -66.5% | -50.1% | -39.4% |
| Return on Assets (ROA) | -49.5% | -38.6% | -33.2% | -30.3% | -28.5% | -53.2% | -42.0% | -35.2% |
| Current Ratio | 6.79x | 11.22x | 19.04x | 15.02x | 17.82x | 7.66x | 8.33x | 14.96x |
| Quick Ratio | 6.69x | 11.15x | 18.94x | 14.96x | 17.72x | 7.28x | 7.56x | 14.28x |
| Debt to Equity | 0.06x | 0.06x | 0.05x | 0.05x | 0.05x | 0.11x | 0.06x | 0.05x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | -100.0% | -- | -- |